Last reviewed · How we verify
Joint pain
Approved treatments
- Magan
- Norgesic · Hikma
- Norgesic · Endo
Orphenadrine citrate centrally acts on brain stem to selectively block facilitatory reticular functions. - Methyl 3-Pyridinecarboxylate
- Acetaminophen · Polymedica
Acetaminophen works by blocking pain signals in the brain. - Aleve · Generic (originally Syntex)
Reversibly inhibits COX-1 and COX-2 with a long half-life, providing sustained anti-inflammatory, analgesic, and antipyretic effects.
Clinical guidelines
- FDA label — 1L
temporarily relieves minor joint pain
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Joint pain patent landscape — cliff calendar, originator estates, attackable patents
- Joint pain treatment landscape brief
- Joint pain treatment updates RSS
Frequently asked questions about Joint pain
What drugs treat Joint pain?
Tracked treatments include Magan, Norgesic, Methyl 3-Pyridinecarboxylate, Acetaminophen, Aleve.
What is the treatment for Joint pain?
Standard treatment for Joint pain includes Magan, Norgesic, Methyl 3-Pyridinecarboxylate, Acetaminophen, Aleve. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Joint pain?
FDA label publishes guidelines for Joint pain. 1 guideline references tracked.
Related
- Treatment landscape: Joint pain patent cliff · Joint pain CI report
- Treatment: Magan
- Treatment: Norgesic · Hikma
- Treatment: Norgesic · Endo
- Treatment: Methyl 3-Pyridinecarboxylate
- Treatment: Acetaminophen · Polymedica
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing